125,449 Sales Calls. Nobody Was Listening to Any of Them. Then 1,368 Purchase Conversations Started Showing Up.
A pharmaceutical and animal-health distributor with a large, decentralised field-sales team was recording every call — and analysing none of them. LeadIcon's AI Rx Intelligence layer turned a year of call audio into a fully structured sales pipeline, complete with demand signals, competitor tracking, and at-risk deal alerts.
A Large Field-Sales Team. A Year of Call Recordings. Zero Structured Intelligence.
PharmSource runs a large, decentralised field-sales organisation — dozens of reps making tens of thousands of calls a month to pharmacies, hospitals and clinics across all 50 states, split across Human Health and Animal Health divisions. Every call was recorded. None of it was structured.
Reps discussed drug availability, fielded demand, and absorbed pricing pushback from competitors like McKesson and Cardinal — but that intelligence lived and died inside individual conversations. Sales leadership had visibility into shipped orders, but no visibility into the moment demand was actually created.
Core Problems Identified
- 125,449 call recordings a year with zero structured analysis
- No way to see which drugs were being requested before an order was placed
- Competitor mentions went untracked at the point of conversation
- Purchase discussions could go 7+ days without follow-up, with no alert
- No link between a rep's call activity and the revenue it produced
Business Impact (Pre-Engagement)
- Demand signals discovered only after a competitor had already won the account
- No predictive view of which drugs were about to see order growth
- Rep coaching based on call volume, not call quality or outcome
- Revenue-per-call and rep verification rate were unmeasurable
- An estimated $497K+ in mid-pipeline opportunity sat invisible inside call audio
The AI Rx Intelligence Layer, Deployed in Four Phases
We turned every recorded call into structured data
Ingested and processed 125,449 call recordings (124,565 analysed successfully — 99.3%), capturing every drug mention, demand signal and competitor reference across both Human Health and Animal Health divisions.
We built an AI-constructed sales pipeline out of conversation alone
From 30,987 drug mentions, the system isolated 1,810 genuine demand signals, then 1,368 real purchase discussions — a pipeline stage that didn't exist before this deployment, drawn entirely from call audio rather than CRM entries.
We connected the pipeline to competitors, geography and revenue
Geo intelligence mapped over $70M in tracked revenue and 1,018 open opportunities across the pharmacy network, while competition-sentiment tracking surfaced exactly which reps were losing ground to McKesson, Cardinal and Vetco, and on which drugs.
We flagged the deals sales was about to lose
At-risk deal intelligence continuously scans for purchase discussions with no follow-up in 7+ days — surfacing 1,198 at-risk deals and $497,472 in identified pipeline value for reps to act on before it goes cold.
The call intelligence layer showed us demand we didn't know existed, and the at-risk deal alerts alone paid for the system.
Placeholder — swap for an actual PharmSource quote and confirm name/title with the client before publishing.
Measurable Impact Across Every Dimension of the Sales Cycle
A 99.3% success rate turning raw call audio into structured intelligence, across 80,794 calls represented in the detailed environment.
From drug mention to demand signal (1,810) to purchase discussion (1,368) to verified closed sale (7) — a fully AI-constructed view of the sales cycle.
Identified directly from call content, independent of CRM or order data.
Purchase discussions with no follow-up for 7+ days, caught before they went cold.
Across 3,548 customers and 1,018 open opportunities, with state-level penetration visibility.
A full account universe covering pharmacies, hospitals and clinics, each scored for activity, revenue and rep coverage.
As a bonus data point, not a headline result: the same system now forecasts next month's order volume (est. 2,458 orders / $2.24M) directly from call and order trends — illustrative projection, not a verified performance figure.
| Metric | Before | After |
|---|---|---|
| Call intelligence | Recorded, never analysed | 124,565 calls structured & searchable |
| Demand visibility | Seen only after an order (or a lost deal) | 1,810 demand signals surfaced from live conversation |
| Competitor tracking | Anecdotal, rep-by-rep | Tracked by rep, drug and region |
| At-risk pipeline | No visibility until the deal was gone | 1,198 at-risk deals flagged automatically |
| Revenue attribution | Shipped orders only | $497,472 in call-attributed pipeline identified |
What PharmSource Says
Placeholder — swap for a real PharmSource testimonial before publishing.
Needs client sign-off before this section goes live.
More From LeadIcon
What's Hiding Inside Your Own Call Archive?
Tell us what your current revenue process looks like. We'll identify where intelligence and automation could create the biggest commercial opportunity.